94.95
0.19 (0.20%)
| Previous Close | 94.76 |
| Open | 93.21 |
| Volume | 1,511,864 |
| Avg. Volume (3M) | 709,164 |
| Market Cap | 8,228,623,360 |
| Price / Earnings (TTM) | 87.11 |
| Price / Earnings (Forward) | 26.32 |
| Price / Sales | 7.36 |
| Price / Book | 3.90 |
| 52 Weeks Range | |
| Earnings Date | 17 Mar 2025 - 21 Mar 2025 |
| Profit Margin | 9.61% |
| Operating Margin (TTM) | 20.24% |
| Diluted EPS (TTM) | 1.09 |
| Quarterly Revenue Growth (YOY) | 23.10% |
| Quarterly Earnings Growth (YOY) | 238.60% |
| Total Debt/Equity (MRQ) | 53.66% |
| Current Ratio (MRQ) | 4.10 |
| Operating Cash Flow (TTM) | 307.74 M |
| Levered Free Cash Flow (TTM) | -192.96 M |
| Return on Assets (TTM) | 3.40% |
| Return on Equity (TTM) | 5.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | HealthEquity, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | -1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.30 |
|
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 2.06% |
| % Held by Institutions | 103.65% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 130.00 (BTIG, 36.91%) | Buy |
| Median | 120.00 (26.38%) | |
| Low | 105.00 (RBC Capital, 10.59%) | Buy |
| Average | 116.57 (22.77%) | |
| Total | 6 Buy, 1 Hold | |
| Avg. Price @ Call | 97.85 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JMP Securities | 10 Dec 2024 | 107.00 (12.69%) | Buy | 95.39 |
| RBC Capital | 10 Dec 2024 | 105.00 (10.58%) | Buy | 95.39 |
| Mizuho | 04 Dec 2024 | 126.00 (32.70%) | Buy | 103.00 |
| Barrington Research | 02 Dec 2024 | 120.00 (26.38%) | Buy | 101.66 |
| Goldman Sachs | 15 Nov 2024 | 108.00 (13.74%) | Hold | 98.98 |
| BTIG | 14 Nov 2024 | 130.00 (36.91%) | Buy | 95.70 |
| B of A Securities | 13 Nov 2024 | 120.00 (26.38%) | Buy | 94.80 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MCCOWAN DEBRA CHARLOTTE | - | 95.00 | -5,000 | -475,000 |
| PARKER STUART B. | - | 95.00 | -25,000 | -2,375,000 |
| ROSNER ELIMELECH | - | 95.00 | -2,869 | -272,555 |
| Aggregate Net Quantity | -32,869 | |||
| Aggregate Net Value ($) | -3,122,555 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 95.00 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MCCOWAN DEBRA CHARLOTTE | Director | 12 Dec 2024 | Sell (-) | 5,000 | 95.00 | 475,000 |
| ROSNER ELIMELECH | Officer | 12 Dec 2024 | Sell (-) | 2,869 | 95.00 | 272,555 |
| PARKER STUART B. | Director | 12 Dec 2024 | Sell (-) | 25,000 | 95.00 | 2,375,000 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |